All News GSK plc

Equities

GSK

GB00BN7SWP63

Real-time Estimate Cboe Europe Other stock markets 07:48:08 2024-06-03 am EDT			5-day change	1st Jan Change
1,599 ^GBX	-9.47%		-8.10%	+10.26%

01:30pm	GSK to Face Trials Over Zantac Cancer Allegations; Shares Tumble Pre-Bell	MT
01:26pm	GSK : Sell rating from JP Morgan	ZD

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK to Face Trials Over Zantac Cancer Allegations; Shares Tumble Pre-Bell	07:30am	MT
GSK : Sell rating from JP Morgan	07:26am	ZD
GSK : Deutsche Bank reiterates its Buy rating	07:08am	ZD
FTSE 100 up, while Labour commits to defence	07:00am	AN
GSK : Goldman Sachs remains Neutral	06:53am	ZD
GSK Shares Plunge After Delaware Ruling Allowing Jury Trials for Zantac Case -- Update	06:21am	DJ
GSK : Blenrep combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma - Form 6-K	06:13am	PU
Statement: Zantac (ranitidine) litigation - Delaware State Court Daubert Ruling - Form 6-K	06:10am	PU
GSK Interim Analysis of Phase III Trial for Blood Cancer Therapy Shows Promise	05:41am	MT
European Midday Briefing : Mood Improves on Fed Rate Cut Hopes	05:36am	DJ
News Highlights : Top Company News of the Day - Monday at 5 AM ET	05:15am	DJ
GSK Shares Plunge After Delaware Ruling on Zantac	04:16am	DJ
GSK vows to appeal adverse Delaware court ruling on Zantac	04:08am	AN
Statement: Zantac (ranitidine) litigation - Delaware State Court Daubert Ruling \| GSK	04:00am	AQ
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to proceed	03:40am	RE
Stocks up amid slew of manufacturing PMIs	03:38am	AN
Blenrep combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma \| GSK	03:29am	AQ
London stocks open nearly 1% higher, eye European rate cut; GSK slumps	03:21am	RE
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward	03:21am	RE
FTSE 100 seen up; GSK defends ranitidine cancer claim	03:02am	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK plc : Back on track

May 03, 2024 at 05:17 am EDT

GSK PLC : Encouraging start to 2024; guidance raised

May 01, 2024 at 11:38 am EDT